Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Obesity
Sort By
Newest First
1 / 1
1 / 1
Announcementan
Biolexis Therapeutics Announces Positive Results from Expanded Diet Induced Obesity (DIO) Model Study for BLX-7006
Biolexis Therapeutics Inc
PR-12-24-NI-133
Dec 10, 2024
Obesity
Gene Therapy in Mice Builds Muscle, Reduces Fat
Washington University School of Medicine
PR-M06-20-NI-037
Jun 30, 2020
Obesity
Kintai Therapeutics Advances Anti-Obesity Agent After Demonstrating Sustained Weight Loss
Kintai Therapeutics
PR-M01-20-NI-039
Jan 28, 2020
Microbiome
Mice Avoid Gaining Weight When Certain Gut Bacteria Are Present
Emilie Branch
Pharma's Almanac
PAO-M08-19-NI-023
Aug 16, 2019
Clinical Trials
Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trials Evaluating Setmelanotide in POMC and LEPR Deficiency Obesities
Nice Insight
PR-M08-19-NI-032
Aug 12, 2019
Genetics
Study Finds Genetics Do Impact Weight
Emilie Branch
Pharma's Almanac
PAO-M05-19-NI-004
May 02, 2019
CRISPR
Gene Amplification Controls Obesity in Mice
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M12-18-NI-018
Dec 19, 2018
Market Prediction
Worldwide Opportunity Outlook on the Anti-obesity Drugs Market to 2022 - Key Players are Eisai, Novo Nordisk and Vivus - ResearchAndMarkets.com
ResearchandMarkets
PR-M12-18-NI-032
Dec 11, 2018
Obesity
The Anti-Obesity Drugs Market Will Register a CAGR of Almost 8% by 2023
Reportbuyer
PR-M12-18-NI-024
Dec 07, 2018
Immunotherapy
Patient Weight Can Impact the Effectiveness of Cancer Immunotherapies
Emilie Branch
Pharma's Almanac
PAO-M11-18-NI-022
Nov 20, 2018
Novel Therapy Targets Obesity-Linked Disease
Nice Insight
PAO-M07-17-NI-035
Jul 28, 2017
